article thumbnail

Society of Nuclear Medicine and Molecular Imaging Names Helen Nadel, MD, FRCPC, of Stanford, as President, Announces New Officers at SNMMI 2023 Annual Meeting

Imaging Technology

The Society introduced a new slate of officers, and recognized new Fellows, during its SNMMI 2023 Annual Meeting , held June 24-27 in Chicago, IL. The potential impact of nuclear medicine in the care of patients dealing with cancer, heart disease, brain disease, and other challenges is enormous,” she said. “We

article thumbnail

Research Showing Genomics- and Image-Guided Subtyping Refines Characterization of Alzheimer’s Disease Presented at SNMMI 2023

Imaging Technology

Based on a novel clustering framework using sparse canonical correlation analysis (SCCA), the integrated approach was successful in identifying four subtypes of Alzheimer’s disease and the top genes associated with each, according to the authors of the study, “An SCCA-clustering framework for Alzheimer’s disease subtyping using tau PET and genomics.”

Disease 75
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study on Value of 68Ga-FAPI PET/CT Imaging for Evaluation of Disease Activity in Rheumatoid Arthritis presented during SNMMI 2023

Imaging Technology

christine.book Mon, 06/26/2023 - 12:46 June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.

Disease 86
article thumbnail

Road to RSNA 2023: Molecular Imaging

AuntMinnie

This is just the third year that RSNA has offered a dedicated track on nuclear medicine and molecular imaging, with eight scientific sessions covering research in prostate cancer imaging, breast cancer, cardiovascular and pulmonary imaging, and more. There will be also 30 educational courses and 14 poster sessions. 9:30 a.m. |

article thumbnail

Prostate Cancer Treatment Study at SNMMI 2023 Finds Improved Patient Outcomes with Personalized Dosing

Imaging Technology

christine.book Thu, 06/29/2023 - 12:17 June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, SNMMI 2023 , found that personalized dosing of men with prostate cancer resulted in improved patient outcomes. Approved by the U.S.

article thumbnail

Treatment paradigm shifting for men with prostate cancer

AuntMinnie

New imaging and treatment strategies are emerging to prolong the lives of men with metastatic castration-resistant prostate cancer (mCRPC), according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

article thumbnail

PET reveals patient responses to new Alzheimer’s disease drug

AuntMinnie

Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. Donanemab is currently under review for approval by the U.S.

Disease 118